Thymalin

Thymalin — Thymic Bioregulatory Peptide for Immunomodulation and Aging Research

Thymalin (also known as Thymaline) is a polypeptide complex originally isolated from the thymus gland, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. As one of the foundational compounds in the Khavinson bioregulatory peptide paradigm, Thymalin has been the subject of over 40 years of research, with more than 100 published studies documenting its immunomodulatory and geroprotective properties. The compound acts on thymic epithelial cells and T-lymphocyte precursors, restoring immune function parameters that decline with age-related thymic involution.

Mechanism of Action

Thymalin acts on the neuroendocrine-immune regulatory axis by modulating thymic microenvironment signaling. Published research in Bulletin of Experimental Biology and Medicine has demonstrated that Thymalin restores the balance between T-helper and T-suppressor lymphocyte populations, normalizes IL-2 receptor expression on T-cells, and stimulates thymulin (FTS) secretion from thymic epithelial cells. The compound also modulates the hypothalamic-pituitary-thymic axis, with studies showing restoration of melatonin and cortisol circadian rhythmicity in aged animal models. Additionally, Khavinson's research published in Advances in Gerontology demonstrated that Thymalin influences telomerase activity in immune cells, potentially counteracting replicative senescence in the lymphocyte compartment.

Key Research Areas

• Immune Restoration: Clinical studies involving over 300 participants published by Khavinson and colleagues demonstrated that Thymalin administration restored T-cell immunity indices in elderly subjects, normalizing CD4/CD8 ratios and enhancing natural killer cell cytotoxicity, establishing it as a reference compound for immune aging research.
• Geroprotection: A landmark 15-year observational study published in Bulletin of Experimental Biology and Medicine (2003) documented a 28% reduction in cardiovascular mortality and a 2.0-fold reduction in overall mortality rate in elderly patients who received periodic Thymalin and Epithalon treatment courses.
• Thymic Involution: Researchers have utilized Thymalin to study the mechanisms of age-related thymic atrophy, demonstrating partial reversal of thymic involution markers including restoration of cortical-medullary architecture and thymocyte populations in aged rodent models.
• Neuroimmune Crosstalk: Published studies have examined how Thymalin modulates the bidirectional communication between the immune and nervous systems, documenting effects on pineal melatonin synthesis, cortisol rhythmicity, and neuropeptide expression patterns in hypothalamic nuclei.

Why Researchers Choose Peptides BioLab

Every batch of Thymalin supplied by Peptides BioLab undergoes rigorous HPLC and mass spectrometry analysis, ensuring ≥98% purity verified by an independent Certificate of Analysis (CoA). Our Thymalin is supplied as a lyophilized powder for maximum stability and shelf life, shipped worldwide from our state-of-the-art facilities in temperature-controlled packaging.

Related Research Peptides

Researchers studying bioregulatory peptides and immunomodulation may also find these compounds relevant: Epithalon, Thymosin Alpha-1, and BPC-157. For a complete overview, browse our Recovery Research collection.

For research purposes only — Not for human consumption. All products are intended solely for in-vitro research and laboratory use.